SCHEMBL2984142

SCHEMBL2984142

Fc1ccccc1-c1nc2ccccn2c1NCc1cccc(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
CASP3 P42574 1/20 0.56
SENP8 Q96LD8 1/20 0.56
SENP7 Q9BQF6 1/20 0.56
SENP6 Q9GZR1 1/20 0.56
PLAU P00749 4/20 0.51
NR1H4 Q96RI1 3/20 0.48
GAA P10253 5/20 0.48
MAPT P10636 5/20 0.48
KDM4E B2RXH2 4/20 0.48
ALDH1A1 P00352 4/20 0.48
HPGD P15428 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SALL4 Q9UJQ4 1/20 0.45
TP53 P04637 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2988118 0.87 L3MBTL1 (0.56) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL2992308 0.87 NR1H4 (0.58) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL2985937 0.85 L3MBTL1 (0.67) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL2977931 0.84 PLAU (0.68) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL20889506 0.82 CASP3 (0.54) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL2979969 0.80 KDM4E (0.66) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL2977653 0.80 CASP3 (0.67) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL20889508 0.80 NR1H4 (0.57) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL2986370 0.80 CASP3 (0.63) L3MBTL1CASP3SENP8SENP7SENP6
SCHEMBL2989998 0.80 NR1H4 (0.66) L3MBTL1CASP3SENP8SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US claimed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO claimed
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC. 2010-07-08 US disclosed
WO-2008016648-A2 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS CYTOKINETICS, INCORPORATED (US) 2008-02-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100173930-A1 Certain Chemical Entities, Compositions and Methods TNNC1, TNNI3, TNNT2 L3MBTL1 2140/4885CASP3 2997/4885SENP8 2710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.